Dashboard
Manage Tickers

MXCTMAXCYTE, INC.

Nasdaq maxcyte.com


$ 4.55 $ -0.16 (-3.4 %)    

Tuesday, 14-May-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 445.89 $ 2.81 (0.63 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.25 (0.43 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.87 (0.86 %)
$ 4.71
$ 4.76
$ 0.00 x 0
$ 4.55 x 327
$ 4.54 - $ 4.82
$ 2.45 - $ 5.55
194,081
na
492.4M
$ 1.30
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-12-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-15-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-22-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 09-13-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-upstart-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Upstart Shares Are Trading Lower By Ar...
05/08/2024 17:38:56

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
05/08/2024 16:31:09

louisiana-pacific-posts-upbeat-results-joins-cricut-elanco-animal-american-public-education-and-other-big-stocks-moving-higher-on-wednesday
Louisiana-Pacific Posts Upbeat Results, Jo...
05/08/2024 15:11:22

maxcyte-affirms-2024-revenue-guidance-for-core-business-revenue-to-be-flat-to-5-growth
MaxCyte Affirms 2024 Revenue Guidance For ...
05/07/2024 21:24:07

MaxCyte expects to end 2024 with at least $175 million in total cash, cash equivalents and investments.

maxcyte-q1-2024-gaap-eps-009-beats-012-estimate-sales-11342m-beat-7462m-estimate
MaxCyte Q1 2024 GAAP EPS $(0.09) Beats $(0...
05/07/2024 20:44:41

MaxCyte (NASDAQ:MXCT) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.12) by 25...

stephens--co-reiterates-overweight-on-maxcyte-maintains-11-price-target
Stephens & Co. Reiterates Overweight on Ma...
04/23/2024 15:22:51

Stephens & Co. analyst Jacob Johnson reiterates MaxCyte (NASDAQ:MXCT) with a Overweight and maintains $11 price target.

maxcyte-signs-strategic-platform-license-with-be-biopharma-terms-not-disclosed
MaxCyte Signs Strategic Platform License W...
04/02/2024 12:09:31

why-taysha-gene-therapies-shares-are-trading-higher-by-around-27-here-are-20-stocks-moving-premarket
Why Taysha Gene Therapies Shares Are Tradi...
03/20/2024 12:20:39

Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a y...

harrow-posts-weak-q4-results-joins-terawulf-nasdaq-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Harrow Posts Weak Q4 Results, Joins TeraWu...
03/20/2024 09:32:36

U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday.

stephens--co-reiterates-overweight-on-maxcyte-maintains-11-price-target
Stephens & Co. Reiterates Overweight on Ma...
03/13/2024 16:02:53

Stephens & Co. analyst Jacob Johnson reiterates MaxCyte (NASDAQ:MXCT) with a Overweight and maintains $11 price target.

nvidia-to-rally-around-20-here-are-10-top-analyst-forecasts-for-wednesday
NVIDIA To Rally Around 20%? Here Are 10 To...
03/13/2024 12:51:49

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

btig-maintains-buy-on-maxcyte-lowers-price-target-to-8
BTIG Maintains Buy on MaxCyte, Lowers Pric...
03/13/2024 12:03:11

BTIG analyst Mark Massaro maintains MaxCyte (NASDAQ:MXCT) with a Buy and lowers the price target from $10 to $8.

beauty-health-posts-upbeat-sales-joins-siga-technologies-maxcyte-and-other-big-stocks-moving-higher-in-wednesdays-pre-market-session
Beauty Health Posts Upbeat Sales, Joins SI...
03/13/2024 10:16:13

U.S. stock futures were mixed this morning, with the Nasdaq futures falling by around 20 points on Wednesday.

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
03/12/2024 21:33:26

maxcyte-expects-fy24-core-business-revenue-to-be-flat-to-5-growth-compared-to-2023-and-spl-program-related-revenue-is-expected-to-be-3m-expects-to-end-2024-with-175m-in-total-cash-cash-equivalents-and-investments
MaxCyte Expects FY24 Core Business Revenue...
03/12/2024 20:09:39

2024 Revenue GuidanceManagement is reiterating 2024 revenue guidance for core business revenue and SPL Program-related revenue....

maxcyte-q4-eps-005-beats-007-estimate-sales-1566m-beat-1309m-estimate
MaxCyte Q4 EPS $(0.05) Beats $(0.07) Estim...
03/12/2024 20:08:27

MaxCyte (NASDAQ:MXCT) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28...

earnings-scheduled-for-march-12-2024
Earnings Scheduled For March 12, 2024
03/12/2024 09:35:47

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

maxcyte-earnings-preview
MaxCyte Earnings Preview
03/11/2024 15:02:21

maxcyte-sees-prelim-fy23-revenue-411m-413m-vs-39774m-est
MaxCyte Sees Prelim. FY23 Revenue $41.1M-$...
03/04/2024 21:08:27

maxcyte-sees-fy24-core-revenue-flat-to-5-growth-yoy-spl-program-related-revenue-3m
MaxCyte Sees FY24 Core Revenue Flat To 5% ...
03/04/2024 21:08:15

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION